BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//N2 Canada - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:N2 Canada
X-ORIGINAL-URL:https://n2canada.ca
X-WR-CALDESC:Events for N2 Canada
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Edmonton
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20230312T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20231105T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20240310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20241103T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20260308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20261101T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Winnipeg
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250415T120000
DTEND;TZID=America/Toronto:20250415T133000
DTSTAMP:20250201T002908Z
CREATED:20250116T012342Z
LAST-MODIFIED:20250201T002908Z
UID:14342-1744718400-1744723800@n2canada.ca
SUMMARY:Optimizing Ethical Research: Implementing Ongoing Consent Models in Neonatal Studies with Georg Schmolzer\, Betsy Pilson and Rebecca Pearce
DESCRIPTION:CHEER Webinar Series 2024-2025: Optimizing Ethical Research: Implementing Ongoing Consent Models in Neonatal Studies with Georg Schmolzer\, Betsy Pilson and Rebecca Pearce
URL:https://n2canada.ca/event/optimizing-ethical-research-implementing-ongoing-consent-models-in-neonatal-studies-with-georg-schmolzer-betsy-pilson-and-rebecca-pearce/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2025/01/CHEER-Webinar-Series-2024-2025-Reimagining-Indigenous-Research-Ethics-in-Canada-Charting-a-New-Course-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250409T110000
DTEND;TZID=America/Toronto:20250409T120000
DTSTAMP:20250318T230818Z
CREATED:20250318T230818Z
LAST-MODIFIED:20250318T230818Z
UID:14502-1744196400-1744200000@n2canada.ca
SUMMARY:Practical Considerations for Clinical Trials in Rare Disease Drug Development
DESCRIPTION:
URL:https://n2canada.ca/event/practical-considerations-for-clinical-trials-in-rare-disease-drug-development/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2025/03/Copy-of-PCRC-HC-20250305-Presentation.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Edmonton:20250324T080000
DTEND;TZID=America/Edmonton:20250324T110000
DTSTAMP:20250312T213352Z
CREATED:20250312T213352Z
LAST-MODIFIED:20250312T213352Z
UID:14477-1742803200-1742814000@n2canada.ca
SUMMARY:RareKids-CAN Virtual Roundup Session
DESCRIPTION:RareKids-CAN is hosting a virtual roundup information session on March 24\, 2025\, from 8–11am MST — and it’s a great opportunity to connect\, learn\, and grow within the rare disease community. \nDuring this session\, you’ll: \n\nLearn more about the RareKids-CAN initiative\nBuild meaningful connections\nExplore ways to stay engaged and informed
URL:https://n2canada.ca/event/rarekids-can-virtual-roundup-session/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2025/03/Inclusive-Practices-in-Race-Data-Collection-Register-Now-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250318T130000
DTEND;TZID=America/Toronto:20250318T150000
DTSTAMP:20250507T004310Z
CREATED:20250312T210737Z
LAST-MODIFIED:20250507T004310Z
UID:14470-1742302800-1742310000@n2canada.ca
SUMMARY:Webinar: Inclusive Practices in Race Data Collection
DESCRIPTION:We are excited to announce two upcoming webinars on inclusive practices in race data collection. These sessions will be facilitated by Dr. Nicole Kaniki from Senomi Solutions Inc. See attached agenda for more details. Please register for ONE session only. \nAfter registering\, you will receive a confirmation email containing information about joining the meeting. Questions can be submitted in advance: https://app.sli.do/event/96R5UBdhZAc2L1hqaVhB2V. We look forward to seeing you there! \nInclusive Practices in Race Data Collection   \nDescription: Participants will review concepts of race and the socio-cultural implications of collecting race-based data. This will ensure a foundational understanding of the language of race that can be communicated to research participants in an accessible and inclusive way. Through scenario-based exercises\, participants will develop best practices for interactions with diverse research participant populations when collecting race-based data. \nWorkshop Objectives: \n\nUnderstand the ethical and socio-cultural implications of demographic data collection.\nIdentify common pitfalls and biases in demographic data collection.\nLearn inclusive best practices for engaging diverse research participants in answering demographic questions.\nExplore real-world examples and apply culturally sensitive data collection techniques.\nDevelop strategies for responsible and transparent data usage.\nEngage diverse populations in a respectful and meaningful way.
URL:https://n2canada.ca/event/inclusive-practices-in-race-data-collection-register-now/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2025/03/Inclusive-Practices-in-Race-Data-Collection-Register-Now.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250317T010000
DTEND;TZID=America/Toronto:20250317T150000
DTSTAMP:20250507T004355Z
CREATED:20250312T210536Z
LAST-MODIFIED:20250507T004355Z
UID:14465-1742173200-1742223600@n2canada.ca
SUMMARY:Webinar: Inclusive Practices in Race Data Collection
DESCRIPTION:We are excited to announce two upcoming webinars on inclusive practices in race data collection. These sessions will be facilitated by Dr. Nicole Kaniki from Senomi Solutions Inc. See attached agenda for more details. Please register for ONE session only: \nAfter registering\, you will receive a confirmation email containing information about joining the meeting. Questions can be submitted in advance: https://app.sli.do/event/96R5UBdhZAc2L1hqaVhB2V. We look forward to seeing you there! \nInclusive Practices in Race Data Collection  \nDescription: Participants will review concepts of race and the socio-cultural implications of collecting race-based data. This will ensure a foundational understanding of the language of race that can be communicated to research participants in an accessible and inclusive way. Through scenario-based exercises\, participants will develop best practices for interactions with diverse research participant populations when collecting race-based data.  \nWorkshop Objectives: \n\nUnderstand the ethical and socio-cultural implications of demographic data collection.\nIdentify common pitfalls and biases in demographic data collection.\nLearn inclusive best practices for engaging diverse research participants in answering demographic questions.\nExplore real-world examples and apply culturally sensitive data collection techniques.\nDevelop strategies for responsible and transparent data usage.\nEngage diverse populations in a respectful and meaningful way.
URL:https://n2canada.ca/event/webinar-inclusive-practices-in-race-data-collection-register-now/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2025/03/Inclusive-Practices-in-Race-Data-Collection-Register-Now.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250305T120000
DTEND;TZID=America/Toronto:20250305T143000
DTSTAMP:20250224T194307Z
CREATED:20250224T194307Z
LAST-MODIFIED:20250224T194307Z
UID:14444-1741176000-1741185000@n2canada.ca
SUMMARY:Health Canada & Clinical Trial Compliance: Navigating Inspections\, Regulations\, and Best Practices
DESCRIPTION:Join us for an engaging webinar that delves into the evolving landscape of Health Canada | Santé Canada & Clinical Trial Compliance. This session is designed to support professionals who navigate the complexities of inspections\, regulations\, and best practices in clinical trials for drugs involving human subjects.  \nIn our session\, we’ll cover:\n▪️ Clinical Trial Compliance Program Overview\n▪️ Inspection Strategy for Clinical Trials\n▪️ International & National Collaboration and Harmonization Efforts\n▪️ Guide 0100 Guidance Document\n▪️ Inspection Process\n▪️ Guide 43: Risk Classification of Observations\n▪️ What Happens After the Inspection?\n▪️ Q&A \nDate & Time:\n Wednesday\, March 5\, 2025 |  12:00-2:30 PM EST \nHosted in collaboration with Hamilton Health Sciences & the Research Connect Pan-Canadian Network \nThis is a wonderful opportunity to gain clarity on compliance\, connect with industry peers\, and enhance your understanding of regulatory inspections in a supportive environment. \nWe look forward to seeing you there!
URL:https://n2canada.ca/event/health-canada-clinical-trial-compliance/
LOCATION:Zoom
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2025/02/Copy-of-PCRC-HC-20250305-Presentation.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250305T120000
DTEND;TZID=America/Toronto:20250305T130000
DTSTAMP:20241223T190019Z
CREATED:20241223T185954Z
LAST-MODIFIED:20241223T190019Z
UID:14156-1741176000-1741179600@n2canada.ca
SUMMARY:Initiating Clinical Trials in Canada
DESCRIPTION:
URL:https://n2canada.ca/event/initiating-clinical-trials-in-canada/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/12/Screenshot-2024-12-23-at-8.56.51 AM.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20250228T120000
DTEND;TZID=America/Vancouver:20250228T130000
DTSTAMP:20250213T200531Z
CREATED:20250213T200512Z
LAST-MODIFIED:20250213T200531Z
UID:14430-1740744000-1740747600@n2canada.ca
SUMMARY:KT Connects – Open science in health research: lessons learned and reflections on the path forward for B.C.
DESCRIPTION:Register for the KT Connects Open Science Webinar\nHosts:\n\nKevin Sauvé – Program Manager\, Science Initiative\, Michael Smith Health Research BC\nDr. Codie Primeau – Arthritis Research Canada; Assistant Professor\, Western University\n\nSpeakers:\n\nDr. Linda Li – Senior Scientist\, Arthritis Research Canada; Professor\, UBC; Scientific Director\, BC SUPPORT Unit (part of Michael Smith Health Research BC)\nGayle Scarrow – Director\, Knowledge Translation\, Michael Smith Health Research BC\nDr. Stirling Bryan – Chief Scientific Officer\, Michael Smith Health Research BC; Professor\, UBC; Senior Scientist\, Centre for Clinical Epidemiology & Evaluation\n\nWebinar Details:\n Friday\, February 28 12 – 1 p.m. PST \nIn 2024\, KT Connects focused on open science—the practice of making scientific knowledge\, resources\, and processes accessible to all with minimal barriers. This final session in the KT Connects open science webinar series will highlight key insights from this past year’s discussions. \nThe session will begin with a summary of key takeaways\, including:✔️ The nature and purpose of open science✔️ Its role in fostering more equitable research systems✔️ Connections to knowledge translation and community engagement research✔️ Opportunities and challenges in research funding and evaluation \nA roundtable discussion and audience Q&A with health researchers\, knowledge translation experts\, and funders will follow\, exploring what these insights mean for open science in B.C. \nLearning Objectives:\nBy attending\, participants will be able to: Understand key insights from the KT Connects open science webinar series and their relevance to B.C.’s health research system Discuss the role of knowledge translation\, engagement research\, funding\, and policy in advancing open science Engage in conversations about how open science can create a more equitable and impactful health research system in B.C. \n Register now to be part of the conversation! \nSpeaker Bios:\nDr. Linda Li is a Professor in the Department of Physical Therapy at UBC and holds the Harold Robinson/Arthritis Society Chair in Arthritic Diseases. She is the Scientific Director for the BC SUPPORT Unit and a Senior Scientist at Arthritis Research Canada. Her research focuses on digital tools\, such as wearable technology and mobile apps\, to support health professionals in managing chronic diseases. \nGayle Scarrow is the Director of Knowledge Translation at Michael Smith Health Research BC\, leading initiatives to bridge the gap between research evidence and health care practice. Her work focuses on applying research findings to improve health outcomes and inform policy. \nDr. Stirling Bryan is the Chief Scientific Officer at Michael Smith Health Research BC and a health economist with extensive experience in health policy and decision-making. He is a Fellow of the Canadian Academy of Health Sciences and President of the Canadian Association for Health Services & Policy Research. \n Missed the Open Science series? Check out the Open Science webinar playlist or browse all past webinars in the KT Connects archive.
URL:https://n2canada.ca/event/kt-connects-open-science-in-health-research-lessons-learned-and-reflections-on-the-path-forward-for-b-c/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2025/02/5fbd93ed-ba4f-8a7c-7a3f-a30f78b96109.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250211T000000
DTEND;TZID=America/Toronto:20250212T170000
DTSTAMP:20250118T012322Z
CREATED:20240918T215030Z
LAST-MODIFIED:20250118T012322Z
UID:13782-1739232000-1739379600@n2canada.ca
SUMMARY:2025 N2 Annual Conference
DESCRIPTION:The 17th Annual N2 Conference is just around the corner! This virtual event\, happening February 11–12\, 2025 from 12:00–5:00 PM EST daily\, offers you the chance to: \n\nEarn 9.0 Continuing Education Credits for SOCRA and ACRP.\nEngage with a stellar lineup of speakers from leading organizations.\nExplore cutting-edge topics and innovative strategies shaping the future of clinical research.\nView the agenda here.\n\nWhat to Expect?\n\nEngaging Sessions: Gain insights on ethics\, AI\, clinical trial modernization\, and more.\nInteractive Panels: Ask the experts anything during sessions on decentralized clinical trials and data management systems.\nWellness Breaks: Recharge with optional sessions led by The National Ballet of Canada.\nNetworking Opportunities: Connect with like-minded professionals and leading experts from across Canada in our interactive sessions and networking opportunities.\n\nWhat’s New? No Scheduling Conflicts!\nThe FDA recently announced a workshop on ICH E6(R3) for the same date as Day 1 of our conference. Good news: the FDA workshop will be fully recorded\, and all slides and presentations will be available afterward. You can attend the N2 Conference without worrying about missing out on the FDA workshop materials. \nDon’t Wait—The Countdown Is On!\nWith just 30 days to go\, now is the time to secure your spot at this must-attend event! \nRegister Today!\nDon’t miss this opportunity to: \n\nEarn valuable continuing education credits.\nHear from over 20 expert speakers across Canada’s top institutions.\nLearn actionable strategies to improve your clinical research practices.\n\nIf you have any questions\, feel free to contact us at n2@n2canada.ca. \nWe look forward to seeing you at the 17th Annual N2 Conference!
URL:https://n2canada.ca/event/2025-n2-annual-conference/
LOCATION:Zoom
CATEGORIES:N2 Annual Conference
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/09/N2-Annual-Conference-Agenda-2025.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250205T120000
DTEND;TZID=America/Toronto:20250205T133000
DTSTAMP:20250116T012034Z
CREATED:20250116T011135Z
LAST-MODIFIED:20250116T012034Z
UID:14335-1738756800-1738762200@n2canada.ca
SUMMARY:Reimagining Indigenous Research Ethics in Canada: Charting a New Course
DESCRIPTION:CHEER Webinar Series 2024-2025: Reimagining Indigenous Research Ethics in Canada: Charting a New Course with Dr. Sean Hillier. \nEthical research with and alongside Indigenous Peoples and communities has made significant progress over the past decades. However\, many “well-intentioned” research projects still fall short by failing to respect Indigenous sovereignty\, lived experiences\, and cultural values. As scientific innovation advances\, it becomes increasingly critical to develop and implement research ethics frameworks that prioritize Indigenous rights and community-defined goals. \nThis talk examines the urgent need for a paradigm shift in how academic institutions\, industry leaders\, and community partners collaborate with Indigenous Peoples and communities to address the complex challenges arising in our rapidly evolving world. \nDr. Sean Hillier\nDr. Sean Hillier is a Mi’kmaw scholar (Qalipu First Nation). He is theAssociate Dean\, Research & Innovation and associate professor in theFaculty of Health at York University. His collaborative researchprogram spans the topics of aging\, living with HIV and other infectiousdiseases\, and One Health – all with a concerted focus on policyaffecting health care access for Indigenous Peoples. He is a member ofthe Interagency Panel on Research Ethics and is currently the Vice-Chair of the Indigenous Research Ethics Board at York University. Dr.Hillier has been successful in receiving funding from each of the threefederal granting agencies and is the current Inaugural AssociateDirector of the $318 million research project\, Connected Minds: Neuraland Machine Systems for a Healthy Just Society.
URL:https://n2canada.ca/event/reimagining-indigenous-research-ethics-in-canada-charting-a-new-course/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2025/01/CHEER-Webinar-Series-2024-2025-Reimagining-Indigenous-Research-Ethics-in-Canada-Charting-a-New-Course.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20250128T120000
DTEND;TZID=America/Vancouver:20250128T130000
DTSTAMP:20250201T003143Z
CREATED:20250110T200200Z
LAST-MODIFIED:20250201T003143Z
UID:14181-1738065600-1738069200@n2canada.ca
SUMMARY:ASK US: What is CRAFT and its involvement in clinical trials in BC?
DESCRIPTION:People who live far from healthcare sites where clinical trials are primarily offered can often experience barriers to participating in trials. \nThe Canadian Remote Access Framework for Clinical Trials (CRAFT) helps enable clinical trial participation for such patients. By reducing travel times and associated costs\, CRAFT makes trials more accessible to rural and remote populations. In BC\, CRAFT has enabled researchers to open more clinical trials in the North and other rural areas\, leading to increased participation from rural and Indigenous patients. \nThe guest speakers for this episode are Dr. Bernie Eigl\, medical oncologist\, BC Cancer and Dr. Robert Olson\, provincial division head of radiology oncology\, UBC. Our guest speakers were involved in the creation of the CRAFT framework. Dr. Eigl was the recipient of the Service and Support Award and Dr. Olson was the recipient of the Leadership and Advocacy Award for the 2024 Clinical Trials BC Awards. \nRegister for the first ASK US episode of 2025 to hear Drs. Eigl and Olson highlight the successes and challenges of implementing CRAFT nationally and provincially through their hands-on experiences. \nLearning objectives\nThe learner will be able to: \n\nidentify the challenges of partnering with community healthcare providers to provide decentralized clinical trials\nunderstand the benefits of engaging community healthcare providers in research\ndiscuss the benefits of running clinical trials from smaller\, rural-focused centres\n\nSpeakers \n \nDr. Bernie Eigl  \nDeputy head\, department of clinical research\, BC Cancer\, Provincial Health Services Authority (PHSA)   \nDirector\, provincial clinical trials office\, BC Cancer\, PHSA  \nMedical oncologist\, BC Cancer – Vancouver Centre\, PHSA  \nClinical associate professor\, faculty of medicine\, University of British Columbia \nDr. Eigl is a staff medical oncologist at BC Cancer Vancouver Centre\, and clinical associate professor\, University of British Columbia. He is the founding director of the Provincial Clinical Trials Office\, and deputy head\, department of clinical research at BC Cancer. The focus of his roles is to strengthen and further develop the clinical trial capabilities of all six BC Cancer centres\, and to improve access to clinical trials for those living with cancer across British Columbia. His own research interests focus on genitourinary oncology clinical trials and biomarker research\, with a special focus in bladder cancer. \n  \n \nDr. Robert Olson  \nProfessor and head\, division of radiation oncology\, department of surgery\, faculty of medicine\, University of British Columbia  \nExecutive medical director\, BC Cancer – Prince George\, Provincial Health Services Authority \nDr. Rob Olson is a clinician scientist who lives in Prince George\, BC. He is the provincial division head of radiation oncology at UBC. He practices radiation oncology at BC Cancer – Prince George\, where he is the executive medical director\, and predominantly treats breast cancer\, head and neck cancer\, and metastatic disease. He is the lead of several international clinical trials looking at the use of precision radiotherapy in the setting of oligometastatic disease\, where he proudly leads a team of dedicated research staff from northern BC. In his spare time\, he spends time with his family (which includes four kids\, three dogs\, and a cat)\, and he enjoys skiing\, biking\, swimming\, or preferably running.
URL:https://n2canada.ca/event/ask-us-what-is-craft-and-its-involvement-in-clinical-trials-in-bc/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2025/01/ask-us-series.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250123T110000
DTEND;TZID=America/Toronto:20250123T120000
DTSTAMP:20250110T200730Z
CREATED:20241223T185604Z
LAST-MODIFIED:20250110T200730Z
UID:14152-1737630000-1737633600@n2canada.ca
SUMMARY:Securing Funding for Clinical Trials
DESCRIPTION:Webinar objectives: \n\n\nIdentify various funding strategies for pediatric and perinatal clinical trials in Canada\, including academic grants and industry partnerships. \n\n\nDevelop realistic expectations regarding the timeline and effort required to fund clinical trials through shared examples. \n\n\nUnderstand different strategies when approaching industry and academic funders and identify key factors for successful proposals. \n\n\nMeet the speakers! \nEbele Ola VP\, Medical Affairs\, Janssen Canada\nDr. Ebele Ola is the Vice-President of Medical Affairs at Janssen Canada. She leads a team of Medical Affairs Professionals dedicated to the generation\, analysis\, and unbiased dissemination of scientific data to health care professionals\, to support improved patient outcomes. She is a member of the Janssen Canada Leadership Team. \nEbele has been with Janssen in Canada since 2008. Prior to joining Johnson & Johnson\, Ebele was Medical Director and Principal Investigator\, overseeing a team of over 100 clinical research professionals in the conduct of Phase I to Phase III Clinical trials. During this period\, the company grew by 50 percent and inpatient capacity increased four-fold. \nIn 2016\, Ebele was recognized as a Healthcare Businesswomen’s Association Rising Star. She is passionate about Diversity\, Equity\, & Inclusion\, and she is the Executive Sponsor for the Janssen Women’s Leadership & Inclusion. \nEbele obtained her Medical Degree from the University of Toronto in Canada\, followed by a residency in Family Medicine at Mount Sinai Hospital in Toronto and a Sports Medicine Fellowship. Outside of her professional life\, she enjoys salsa dancing and traveling to new destinations with her husband and daughter. \nSrinivas Murthy\nClinical Associate Professor\, Department of Pediatrics\, Faculty of Medicine\, University of British Columbia \nThierry Lacaze-Masmonteil\nScientific Director\, Maternal Infant Child and Youth Research Network (MICYRN)
URL:https://n2canada.ca/event/secure-funding-for-clinical-trials/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/12/Unknown.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Edmonton:20241213T060000
DTEND;TZID=America/Edmonton:20241213T070000
DTSTAMP:20241119T200525Z
CREATED:20241119T200525Z
LAST-MODIFIED:20241119T200525Z
UID:14080-1734069600-1734073200@n2canada.ca
SUMMARY:Webinar: WHO launches new clinical trials guidance – What do I need to know?
DESCRIPTION:The publication of the WHO guidance for best practices for clinical trials in September 2024 was a major milestone. For the first time there is now global guidance applicable to design and conduct of all clinical trials (whether or not they include investigational products)\, also with relevance to observational studies. \nKey areas of focus include embedding research into health systems\, developing sustained networks of continuously active clinical researchers\, greater inclusivity of diverse population groups\, the centrality of the need for interaction between patient/community groups and researchers in the trial life cycle\, simplifying what can be excessively complex and uncoordinated clinical trial approval processes involving many bodies\, and ensuring a risk-based\, proportionate approach to design\, data collection\, oversight and inspection. WHO and The Global Health Network are convening a global event to present the key aspects of this new guidance. \nThis will be an informative opportunity to hear directly from WHO and learn how this guidance can help support and strengthen your research. Live translation will be available.
URL:https://n2canada.ca/event/who-webinar/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/11/Event-Posters-for-Website-LinkedIn-Post.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241121T080000
DTEND;TZID=America/Toronto:20241121T170000
DTSTAMP:20250131T222820Z
CREATED:20240610T235750Z
LAST-MODIFIED:20250131T222820Z
UID:12978-1732176000-1732208400@n2canada.ca
SUMMARY:2024 Investigator Training Program (ITP) - Safety in Clinical Trials
DESCRIPTION:We are excited to announce that “Pan-Canadian Research Connect” is once again offering the Investigator Training Program (ITP) in collaboration with Pfizer. This year\, the program will feature 7 comprehensive modules designed to provide an in-depth overview of the clinical trial process\, offering practical recommendations to enhance the efficiency of clinical trial conduct. \nThe ITP is an excellent opportunity for clinical trial investigators and research staff who are new to clinical trials or who could benefit from a refresher course. Participation and registration are open to all researchers and the research community within the Research Connect Network. Those who attend all seven modules will be eligible to receive a TransCelerate Good Clinical Practices (GCP) Certificate. \nKey Highlights for 2024: \n\nComplete 7 Modules for Certification: This year’s program consists of 7 modules. Full attendance at all modules is required to receive the formal certificate.\nRegister Early: Registration is limited to 500 participants. Please ensure your participation by registering as soon as possible. If you are unable to attend\, kindly cancel your registration to allow others the opportunity to participate.\nMandatory Full Attendance: To obtain the certificate of completion from Pfizer and TransCelerate\, you must attend the entire duration of all 7 modules. Attendance from the start to the end of each webinar is necessary. Missing even 15 minutes may disqualify you from receiving the certificate.\nPre-read Materials: Some modules will have pre-read materials that will be sent to all registered attendees. We strongly encourage an in-depth review of these materials prior to attending the training.\nRetake Requirement for Certification: If you missed any portion of the training last year\, you are required to retake all the modules again this year to receive a formal certificate.\nOptional Refresher: Those who participated last year and wish to retake the modules as a refresher are more than welcome to do so.\n\nSchedule: The webinars will be held from November 12th to November 21st. \nPlease register as soon as possible for this exciting and limited opportunity.
URL:https://n2canada.ca/event/2024-investigator-training-program-itp-safety-in-clinical-trials/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/webp:https://n2canada.ca/wp-content/uploads/2024/06/Webinar-2-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241119T110000
DTEND;TZID=America/Toronto:20241119T121500
DTSTAMP:20250131T222948Z
CREATED:20240610T235504Z
LAST-MODIFIED:20250131T222948Z
UID:12976-1732014000-1732018500@n2canada.ca
SUMMARY:2024 Investigator Training Program (ITP) - Study Oversight Informed Consent
DESCRIPTION:We are excited to announce that “Pan-Canadian Research Connect” is once again offering the Investigator Training Program (ITP) in collaboration with Pfizer. This year\, the program will feature 7 comprehensive modules designed to provide an in-depth overview of the clinical trial process\, offering practical recommendations to enhance the efficiency of clinical trial conduct. \nThe ITP is an excellent opportunity for clinical trial investigators and research staff who are new to clinical trials or who could benefit from a refresher course. Participation and registration are open to all researchers and the research community within the Research Connect Network. Those who attend all seven modules will be eligible to receive a TransCelerate Good Clinical Practices (GCP) Certificate. \nKey Highlights for 2024: \n\nComplete 7 Modules for Certification: This year’s program consists of 7 modules. Full attendance at all modules is required to receive the formal certificate.\nRegister Early: Registration is limited to 500 participants. Please ensure your participation by registering as soon as possible. If you are unable to attend\, kindly cancel your registration to allow others the opportunity to participate.\nMandatory Full Attendance: To obtain the certificate of completion from Pfizer and TransCelerate\, you must attend the entire duration of all 7 modules. Attendance from the start to the end of each webinar is necessary. Missing even 15 minutes may disqualify you from receiving the certificate.\nPre-read Materials: Some modules will have pre-read materials that will be sent to all registered attendees. We strongly encourage an in-depth review of these materials prior to attending the training.\nRetake Requirement for Certification: If you missed any portion of the training last year\, you are required to retake all the modules again this year to receive a formal certificate.\nOptional Refresher: Those who participated last year and wish to retake the modules as a refresher are more than welcome to do so.\n\nSchedule: The webinars will be held from November 12th to November 21st. \nPlease register as soon as possible for this exciting and limited opportunity.
URL:https://n2canada.ca/event/2024-investigator-training-program-itp-study-oversight-informed-consent/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/webp:https://n2canada.ca/wp-content/uploads/2024/06/Webinar-2-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241114T110000
DTEND;TZID=America/Toronto:20241114T123000
DTSTAMP:20250131T223034Z
CREATED:20240610T235249Z
LAST-MODIFIED:20250131T223034Z
UID:12974-1731582000-1731587400@n2canada.ca
SUMMARY:2024 Investigator Training Program (ITP) - Study Start-Up Conducting a Study
DESCRIPTION:We are excited to announce that “Pan-Canadian Research Connect” is once again offering the Investigator Training Program (ITP) in collaboration with Pfizer. This year\, the program will feature 7 comprehensive modules designed to provide an in-depth overview of the clinical trial process\, offering practical recommendations to enhance the efficiency of clinical trial conduct. \nThe ITP is an excellent opportunity for clinical trial investigators and research staff who are new to clinical trials or who could benefit from a refresher course. Participation and registration are open to all researchers and the research community within the Research Connect Network. Those who attend all seven modules will be eligible to receive a TransCelerate Good Clinical Practices (GCP) Certificate. \nKey Highlights for 2024: \n\nComplete 7 Modules for Certification: This year’s program consists of 7 modules. Full attendance at all modules is required to receive the formal certificate.\nRegister Early: Registration is limited to 500 participants. Please ensure your participation by registering as soon as possible. If you are unable to attend\, kindly cancel your registration to allow others the opportunity to participate.\nMandatory Full Attendance: To obtain the certificate of completion from Pfizer and TransCelerate\, you must attend the entire duration of all 7 modules. Attendance from the start to the end of each webinar is necessary. Missing even 15 minutes may disqualify you from receiving the certificate.\nPre-read Materials: Some modules will have pre-read materials that will be sent to all registered attendees. We strongly encourage an in-depth review of these materials prior to attending the training.\nRetake Requirement for Certification: If you missed any portion of the training last year\, you are required to retake all the modules again this year to receive a formal certificate.\nOptional Refresher: Those who participated last year and wish to retake the modules as a refresher are more than welcome to do so.\n\nSchedule: The webinars will be held from November 12th to November 21st. \nPlease register as soon as possible for this exciting and limited opportunity.
URL:https://n2canada.ca/event/2024-investigator-training-program-itp-study-start-up-conducting-a-study/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/webp:https://n2canada.ca/wp-content/uploads/2024/06/Webinar-2-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241114T073000
DTEND;TZID=America/Toronto:20241115T161000
DTSTAMP:20240604T213330Z
CREATED:20240603T222024Z
LAST-MODIFIED:20240604T213330Z
UID:12490-1731569400-1731687000@n2canada.ca
SUMMARY:DIA Canada Annual Meeting
DESCRIPTION:The DIA Canada Annual Meeting will deliver a comprehensive overview of the current pharmaceutical\, medical device\, and/or diagnostic landscapes in Canada\, while sharing insights into Canada’s broader role in global healthcare product development and is separated into three tracks: Regulatory\, Clinical and Safety and Pharmacovigilance. This meeting will connect attendees with leaders and experts in academia and those involved in the regulatory\, clinical\, and safety and pharmacovigilance functional areas in the pharmaceutical and medical device industry to explore best practices\, lessons learned\, and problem-solving strategies effecting stakeholders in Canada. \nN2 Members\, please contact n2@n2canada.ca to receive a discount code for registration. 
URL:https://n2canada.ca/event/dia-canada-annual-meeting/
LOCATION:3 Bd du Casino\, 3 Bd du Casino\, Gatineau\, Quebec\, J8Y 6X4\, Canada
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/Webinar-8.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241114
DTEND;VALUE=DATE:20241115
DTSTAMP:20240816T193018Z
CREATED:20240816T193018Z
LAST-MODIFIED:20240816T193018Z
UID:13469-1731542400-1731628799@n2canada.ca
SUMMARY:Putting Patients First 2024
DESCRIPTION:Putting Patients First (PPF) is an annual conference that advances learning communities to improve health systems. \nThis year\, Putting Patients First 2024 will take place on November 14\, 2024\, in Vancouver\, BC. There is no cost to attend. \nLeaders in the health and health research ecosystems\, from patients to policy makers\, are welcome. This includes health-care providers\, health system decision-makers\, patients\, people with lived experience of health issues and the health care system\, health researchers\, and students and trainees.
URL:https://n2canada.ca/event/putting-patients-first-2024/
LOCATION:Vancouver Marriott Pinnacle Downtown Hotel\, 1128 W Hastings St\, Vancouver\, BC\, V6E 4R5\, Canada
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/08/Event-Posters-for-Website-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241112T120000
DTEND;TZID=America/Toronto:20241112T130000
DTSTAMP:20241023T200634Z
CREATED:20241022T224534Z
LAST-MODIFIED:20241023T200634Z
UID:13861-1731412800-1731416400@n2canada.ca
SUMMARY:Right-Sizing Health Systems for Kids through Research Excellence
DESCRIPTION:If you’re interested in the future of pediatric healthcare\, consider registering for this enlightening webinar hosted by Children’s Healthcare Canada. They’ll delve into how health research is essential for advancing children’s health\, identifying emerging trends\, and innovating new models of care. This event will discuss the importance of integrating research excellence into healthcare systems\, ensuring that investments lead to meaningful improvements for children\, youth\, and families. It’s a great opportunity to learn about the role of research in creating a more accessible and equitable healthcare system tailored for the youngest generations in Canada!
URL:https://n2canada.ca/event/right-sizing-health-systems-for-kids-through-research-excellence/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/10/CHEER-WEBINAR.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241112T110000
DTEND;TZID=America/Toronto:20241112T121500
DTSTAMP:20250131T222603Z
CREATED:20240610T234954Z
LAST-MODIFIED:20250131T222603Z
UID:12969-1731409200-1731413700@n2canada.ca
SUMMARY:2024 Investigator Training Program (ITP) - Clinical Trials Overview Regional Regulation
DESCRIPTION:We are excited to announce that “Pan-Canadian Research Connect” is once again offering the Investigator Training Program (ITP) in collaboration with Pfizer. This year\, the program will feature 7 comprehensive modules designed to provide an in-depth overview of the clinical trial process\, offering practical recommendations to enhance the efficiency of clinical trial conduct. \nThe ITP is an excellent opportunity for clinical trial investigators and research staff who are new to clinical trials or who could benefit from a refresher course. Participation and registration are open to all researchers and the research community within the Research Connect Network. Those who attend all seven modules will be eligible to receive a TransCelerate Good Clinical Practices (GCP) Certificate. \nKey Highlights for 2024: \n\nComplete 7 Modules for Certification: This year’s program consists of 7 modules. Full attendance at all modules is required to receive the formal certificate.\nRegister Early: Registration is limited to 500 participants. Please ensure your participation by registering as soon as possible. If you are unable to attend\, kindly cancel your registration to allow others the opportunity to participate.\nMandatory Full Attendance: To obtain the certificate of completion from Pfizer and TransCelerate\, you must attend the entire duration of all 7 modules. Attendance from the start to the end of each webinar is necessary. Missing even 15 minutes may disqualify you from receiving the certificate.\nPre-read Materials: Some modules will have pre-read materials that will be sent to all registered attendees. We strongly encourage an in-depth review of these materials prior to attending the training.\nRetake Requirement for Certification: If you missed any portion of the training last year\, you are required to retake all the modules again this year to receive a formal certificate.\nOptional Refresher: Those who participated last year and wish to retake the modules as a refresher are more than welcome to do so.\n\nSchedule: The webinars will be held from November 12th to November 21st. \nPlease register as soon as possible for this exciting and limited opportunity.
URL:https://n2canada.ca/event/2024-investigator-training-program-itp-clinical-trials-overview-regional-regulation/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/webp:https://n2canada.ca/wp-content/uploads/2024/06/Webinar-2-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241106
DTEND;VALUE=DATE:20241108
DTSTAMP:20240708T211118Z
CREATED:20240603T203804Z
LAST-MODIFIED:20240708T211118Z
UID:12483-1730851200-1731023999@n2canada.ca
SUMMARY:2024 Clinical Trials Ontario Conference
DESCRIPTION:The CTO Clinical Trials Conference is a leading Canadian forum to drive innovation in clinical trials\, including leaders from the pharmaceutical and medical device industries\, academic and healthcare leaders\, representatives from patient groups\, health charities and research institutions. This annual event provides a unique opportunity for members of our multi-stakeholder sector to collaborate\, exchange knowledge and advance clinical trials.
URL:https://n2canada.ca/event/2024-clinical-trials-ontario-conference/
LOCATION:Hilton Toronto\, 145 Richmond Street West\, Toronto\, Ontario\, M5H 2L2\, Canada
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/CTO-Conference1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241028
DTEND;VALUE=DATE:20241030
DTSTAMP:20241007T235841Z
CREATED:20241007T235656Z
LAST-MODIFIED:20241007T235841Z
UID:13836-1730073600-1730246399@n2canada.ca
SUMMARY:8th Annual Patient-Centered Approach to Clinical Trials Conference
DESCRIPTION:The 8th Annual Patient-Centered Approach to Clinical Trials Conference is fast approaching and this year the theme is: How Are We Advancing Cancer Clinical Trials in Canada? This seminal pan-cancer conference continues to inform clinical trial networks\, researchers\, industry\, and academic trial sponsors\, HTA agencies\, Health Canada\, and national and international cancer patient groups to mention a few. \nThe objectives for this year’s Conference include the following: \n\nTo showcase Canada as fertile ground for Clinical Trials\nTo educate and update on the good work and investments underway that will accelerate the clinical trial landscape in Canada over the new 2 to 3 years \nTo discuss where we are winning/advancing in Canada and where/what are the key barriers that must be addressed \n\nThis year the Conference will be in Montreal on Oct 29-30\, and is being held at the Holiday Inn & Suites\, Montreal Centre-Ville Ouest. \nThe Conference is complementary and this is the Registration link:  https://tinyurl.com/PACT-2024
URL:https://n2canada.ca/event/8th-annual-patient-centered-approach-to-clinical-trials-conference/
LOCATION:Holiday Inn & Suites\, Montreal Centre-Ville Ouest.\, 1390 René-Lévesque Blvd W\, Montreal\, Quebec\, H3G 0E3\, Canada
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/10/Untitled-design.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Winnipeg:20241024T090000
DTEND;TZID=America/Winnipeg:20241024T150000
DTSTAMP:20241010T202625Z
CREATED:20240603T182334Z
LAST-MODIFIED:20241010T202625Z
UID:12405-1729760400-1729782000@n2canada.ca
SUMMARY:N2 Central Regional Meeting
DESCRIPTION:Register for the in-person Central N2 Canada Regional Meeting taking place in Winnipeg\, organized in collaboration with the C4T (The Canadian Collaborative for Childhood Cannabinoid Therapeutics)\, Centre for Healthcare Innovation\, Children’s Hospital Research Institute of Manitoba\, Research Manitoba\, University of Manitoba\, and the University of Saskatchewan. The theme for the event is surrounding Cannabis Trials. Please keep an eye out for details as they become available. \nWe have exciting news! Registration fees covered for Manitoba residents through a grant from Research Manitoba. If you are located outside of Manitoba\, please contact n2@n2canada.ca to process your registration.  \n 
URL:https://n2canada.ca/event/n2-central-regional-meeting/
LOCATION:SmartPark Innovation Hub\, 100 Innovation Dr.\, Winnipeg\, Manitoba\, R3T 6A8\, Canada
CATEGORIES:N2 Regional Meetings
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/Event-Posters-for-Website.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241023
DTEND;VALUE=DATE:20241024
DTSTAMP:20240603T203234Z
CREATED:20240603T203234Z
LAST-MODIFIED:20240603T203234Z
UID:12477-1729641600-1729727999@n2canada.ca
SUMMARY:7th Annual IGNITE Applied Health Research Conference
DESCRIPTION:
URL:https://n2canada.ca/event/7th-annual-ignite-applied-health-research-conference/
LOCATION:Barrie\, Barrie\, Ontario\, Canada
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/Webinar-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241022T130000
DTEND;TZID=America/Toronto:20241022T143000
DTSTAMP:20240918T212737Z
CREATED:20240918T210011Z
LAST-MODIFIED:20240918T212737Z
UID:13778-1729602000-1729607400@n2canada.ca
SUMMARY:N2 Canada 2025 Annual Conference Ideation Workshop
DESCRIPTION:The 2025 N2 Annual Conference will be held on a virtual platform from February 11-12\, 2025\, from 12:00-4:00 PM EST. The Annual Conference is being developed for our members\, and participating in this Conference Ideation Workshop is your opportunity to help shape next year’s conference! Registration in advance is required so that we can develop breakout rooms. \nWorkshop Objectives: \n1. Gather ideas from the N2 community for topics and speakers for the conference \n2. Generate and gather ideas from the N2 community on networking at the conference
URL:https://n2canada.ca/event/n2-canada-2025-annual-conference-ideation-workshop/
LOCATION:Zoom
CATEGORIES:N2 Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/09/A-workshop-on-tidiness.-1600-x-900-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241003T090000
DTEND;TZID=America/Toronto:20241003T170000
DTSTAMP:20240711T184114Z
CREATED:20240711T184011Z
LAST-MODIFIED:20240711T184114Z
UID:13168-1727946000-1727974800@n2canada.ca
SUMMARY:Adaptive Platform Trials Scientific Meeting
DESCRIPTION:The APT Scientific Meeting is for clinical trialists\, clinical investigators\, statisticians\, trial methodologists\, health economists\, trainees\, policymakers\, patient advocates\, and anyone interested in using\, designing\, and implementing platform trials. \nLearning objectives: \n\nUnderstand the key elements of designing and implementing an adaptive platform trial.\nGain insights into the operational aspects of adaptive platform trials\, such as protocol development\, CRF design\, data management\, and the role of standardization and operational documents.\nUnderstand the importance of pre-trial model-based simulations and interim statistical analyses for adaptive platform trials.\nLearn about the ethical considerations\, best practices\, and the role of Research Ethics Boards (REBs) in operationalizing ethical guidelines throughout adaptive platform trials.\nExplore strategies for effective engagement and involvement of participants\, including patients and other stakeholders\, in the adaptive platform trial process.\n\nScientific committee members: Drs. Andrew Pinto\, Benita Hosseini (Chair)\, Lisa Schwartz\, Robert Fowler\, and Shirin Golchi
URL:https://n2canada.ca/event/adaptive-platform-trials-scientific-meeting/
LOCATION:Chestnut Conference Centre\, 89 Chestnut Street\, Toronto\, Ontario\, M5G 1R1\, Canada
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/07/Event-Posters-for-Website-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240927
DTEND;VALUE=DATE:20240930
DTSTAMP:20240715T174821Z
CREATED:20240715T174821Z
LAST-MODIFIED:20240715T174821Z
UID:13217-1727395200-1727654399@n2canada.ca
SUMMARY:2024 SOCRA Annual Conference
DESCRIPTION:Join over 1\,000 of your colleagues at SOCRA’s Annual Conference! Each year\, SOCRA gathers clinical research professionals from around the world. Immerse yourself in this three-day conference filled with current information\, essential tools\, best practices\, and comprehensive training to ensure your clinical research practice remains up-to-date and compliant. The program boasts expert-led academic sessions\, interactive workshops\, ample networking opportunities\, a peer-driven poster session\, and an engaging exhibit program. Don’t miss this chance to connect\, learn\, and stay at the forefront of the industry. View agenda. \n 
URL:https://n2canada.ca/event/2024-socra-annual-conference/
LOCATION:Westgate Resort Las Vegas\, 3000 Paradise Road\, Las Vegas\, NV\, 89109\, United States
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/07/Event-Posters-for-Website-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240925T070000
DTEND;TZID=America/Toronto:20240925T083000
DTSTAMP:20240919T173912Z
CREATED:20240919T173315Z
LAST-MODIFIED:20240919T173912Z
UID:13792-1727247600-1727253000@n2canada.ca
SUMMARY:Launch webinar for WHO guidance for best practices for clinical trials
DESCRIPTION:Register for the WHO Webinar on 25 September which will launch the WHO guidance and detailed recommendations for national health authorities\, regulatory authorities\, funders and others on how best they can facilitate clinical trials and research. The guidance refers to several CIOMS documents. We are proud to say that the recommendations were adapted directly from the 2021 CIOMS Working Group report on Clinical research in resource-limited settings.
URL:https://n2canada.ca/event/launch-webinar-for-who-guidance-for-best-practices-for-clinical-trials/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/09/WHO-Webinar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20240917T120000
DTEND;TZID=America/Vancouver:20240917T130000
DTSTAMP:20240816T192348Z
CREATED:20240816T192348Z
LAST-MODIFIED:20240816T192348Z
UID:13465-1726574400-1726578000@n2canada.ca
SUMMARY:WHO Guidance for Best Practices for Clinical Trials
DESCRIPTION:Clinical trials have a central role in generating the evidence needed to inform the development and implementation of health interventions. This is because they can reliably determine whether a health intervention has any effect by ensuring that any biases or random errors inherent in the study design are small with respect to the expected treatment effect. The results have been transformative in advancing global public health.  \nThe intent of the ‘World Health Organization guidance for best practices for clinical trials’ document is to support implementation of universal ethical and scientific standards and strengthen the clinical trial ecosystem\, with a focus on under-represented populations. It is also complementary to other good clinical practice initiatives.  \nJoin us for an overview presentation on the WHO document which spans all regions and nations and is applicable across all health product lines: any design\, health intervention\, purpose\, setting and role.  \nTarget audience \nAny clinical trial staff member whose work is related to clinical trials in any way. This includes in planning\, conduct\, analysis\, oversight\, interpretation\, education and funding of all clinical trials in which randomization is used to assess the effects of any health intervention for any purpose in any setting.  \nLearning objectives \nThe learner will be able to:  \n\nhave an awareness of the main issues and steps required to facilitate good clinical trials and reduce waste\, \nidentify the qualities of a well-designed\, well-implemented and clinically relevant trial\, \nuse a framework and tools to self-evaluate whether a team has adequate infrastructure (physical and trial personnel) required to conduct an efficient high-quality trial\, \nlist the competencies that should be demonstrated by a clinical research team to undertake a successful study\, \nlead a discussion on the strenuous efforts needed to be made\, to recruit diverse populations to clinical trials.\n \n\nPresenter\n \n  \n  \n  \n  \n  \n  \nJean Smart\, PhD\, MGH\, MIDS \nRegulatory Affairs & Quality Officer\, Clinical Trials BC
URL:https://n2canada.ca/event/who-guidance-for-best-practices-for-clinical-trials/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/08/Event-Posters-for-Website.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240912T110000
DTEND;TZID=America/Toronto:20240912T120000
DTSTAMP:20240816T215611Z
CREATED:20240816T215611Z
LAST-MODIFIED:20240816T215611Z
UID:13473-1726138800-1726142400@n2canada.ca
SUMMARY:Pan-Canadian Research Connect Presents: ALS Breakthroughs: A New Dawn in Neurological Research
DESCRIPTION:Dr. Michael Strong will share groundbreaking insights into ALS research\, discussing the latest advancements and their implications for the future of neurological studies. \nThis is a unique opportunity to gain knowledge from one of the leading experts in the field and to engage in an enriching discussion with the research community about: \n\nThe current understanding of ALS\nThe latest discoveries in ALS pathogenesis\nRecent advancements in ALS research\nNew therapeutic approaches\n\nDr. Strong is a distinguished figure in the field of neurological research\, serving as the past president of the Canadian Institutes for Health Research. He is also a distinguished university professor at Western University\, dean emeritus of the Schulich School of Medicine and Dentistry\, and the Arthur J. Hudson Chair in ALS Research.
URL:https://n2canada.ca/event/pan-canadian-research-connect-presents-als-breakthroughs-a-new-dawn-in-neurological-research/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/08/Event-Posters-for-Website-3.png
END:VEVENT
END:VCALENDAR